Does restoring neuronal AMPK activity reverse microglial inflammation in vivo?¶
Notebook ID: nb-SDA-2026-04-26-gap-pubmed-20260410-180918-962b1ada-debate · Analysis: SDA-2026-04-26-gap-pubmed-20260410-180918-962b1ada-debate
Domain: neurodegeneration · Date: 2026-04-25
Research Question¶
The study establishes the pathway from AMPK loss to microglial inflammation but doesn't address therapeutic reversibility. This gap is critical for determining whether AMPK represents a viable therapeutic target for neuroinflammatory diseases.
Gap type: open_question Source paper: Neuronal AMPK regulates lipid transport to microglia. (None, None, PMID:39241754)
Debate Summary¶
Debate transcript not available for this analysis.
Hypotheses Ranked by Composite Score¶
Total hypotheses: 7
| Title | Composite | Confidence | Novelty | Feasibility | Impact |
|---|---|---|---|---|---|
| NLRP3 Inhibition (H7): Downstream Inflammatory Reversal | 0.78 | 0.78 | 0.7 | 0.8 | 0.85 |
| Neuronal AMPK Restoration (H1): Direct Reversibility Test | 0.68 | 0.82 | 0.9 | 0.45 | 0.7 |
| FABP5/7 Inhibition (H2): Lipid Relay Interruption | 0.67 | 0.65 | 0.75 | 0.7 | 0.68 |
| Autophagy Activation ULK1/VPS34 (H3): Lipid Routing to Lysosomes | 0.6 | 0.72 | 0.78 | 0.55 | 0.6 |
| LXR Agonism (H4): Microglial Lipid Efflux Promotion | 0.58 | 0.62 | 0.6 | 0.55 | 0.5 |
| Metabolic Rescue PDH Activation (H5): Indirect Lipogenesis Suppression | 0.55 | 0.55 | 0.58 | 0.45 | 0.52 |
| Astrocyte-Neuron Lactate Shuttle (H6): Metabolic Coupling Restoration | 0.5 | 0.52 | 0.65 | 0.4 | 0.48 |
Knowledge Graph Edges¶
No KG edges found for this analysis.
Key Citations¶
No citations found for this analysis.